Publicaciones en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (8)

2023

  1. Brodalumab: Efficacy, safety, and survival in mid-term (52 weeks) on real clinical practice in Andalucia, Spain

    International Journal of Dermatology, Vol. 62, Núm. 5, pp. 700-706

2021

  1. Secukinumab: Drug Survival in Clinical Practice Settings

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 4, pp. 361-364

2020

  1. A Review of the Latest Recommendations on the Management of Chronic Urticaria: A Multidisciplinary Consensus Statement from Andalusia, Spain

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 3, pp. 222-228

  2. Drug survival, discontinuation rates, and safety profile of secukinumab in real-world patients: a 152-week, multicenter, retrospective study

    International Journal of Dermatology, Vol. 59, Núm. 5, pp. 633-639

2019

  1. Dupilumab: short-term effectiveness and security in real clinical practice – A retrospective multicentric study

    Journal of the European Academy of Dermatology and Venereology

  2. Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series

    Dermatologic Therapy, Vol. 32, Núm. 4

2018

  1. Adult atopic dermatitis: From physiopathology to therapeutics (II)

    Piel

2014

  1. The role of accessibility policies and other determinants of health care provision in the initial prognosis of malignant melanoma: A cross-sectional study

    Journal of the American Academy of Dermatology, Vol. 71, Núm. 3, pp. 507-515